Another potential regulator of caspase-8 activation is c-FLIP, a catalytically inactive caspase-8 homologue, which has been implicated in TRAIL resistance in HER2-positive breast cancer cells [51] and to be downregulated in association with increased TRAIL sensitivity during endocrine resistance [52]. This evidence concerns the gene ERBB2 and breast cancer.